Skip to content

Impact of Humeral Component Version on Outcomes Following RTSA

The Impact of Humeral Component Version on Outcomes Following Reverse Total Shoulder Arthroplasty: A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03111147
Enrollment
95
Registered
2017-04-12
Start date
2017-05-12
Completion date
2023-05-23
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Tear Arthropathy

Brief summary

The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.

Detailed description

Retrospective clinical evidence suggests that increasing humeral component retroversion does not affect measured internal or external rotation, however patients with neutral version may experience better function with daily activities requiring internal rotation compared to those with 30 degrees of retroversion. Prospective data on clinical outcomes comparing different humeral component versions in RTSA is currently lacking. The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.

Interventions

DEVICE0 degrees humeral component version

RTSA with humeral component positioned in 0 degrees of version

DEVICE30 degrees humeral component retroversion

RTSA with humeral component positioned in 30 degrees of retroversion

Sponsors

Corewell Health East
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing primary reverse total shoulder arthroplasty * Diagnosis of cuff tear arthropathy or primary OA with RCT * Intact posterior rotator cuff and subscapularis preoperatively, as determined by surgeon-administered physical exam * 18 years or older

Exclusion criteria

* Revision arthroplasty * Diagnosis of rheumatoid arthritis, infection, acute trauma or instability * Minors (under 18 years of age) * Prior open shoulder surgery * Concomitant latissimus dorsi transfer * Patients not undergoing a standard of care physical therapy protocol * Pregnant, patient-reported * Cognitively impaired

Design outcomes

Primary

MeasureTime frameDescription
Postoperative External Range of Motion (ROM)2 yearsExternal range of motion measurements of the shoulder in degrees
Postoperative Internal Range of Motion (ROM)2 yearsInternal range of motion measurements of the shoulder in degrees

Countries

United States

Participant flow

Pre-assignment details

Of 95 patients recruited, 85 met inclusion criteria and were randomized to treatment groups.

Participants by arm

ArmCount
0 Degrees Humeral Component Version
Reverse Total Shoulder Arthroplasty with humeral component positioned in 0 degrees of version 0 degrees humeral component version: RTSA with humeral component positioned in 0 degrees of version
42
30 Degrees Humeral Component Retroversion
Reverse Total Shoulder Arthroplasty with humeral component positioned in 30 degrees of retroversion 30 degrees humeral component retroversion: RTSA with humeral component positioned in 30 degrees of retroversion
43
Total85

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath11
Overall StudyLost to Follow-up25
Overall StudyProtocol Violation21
Overall StudyWithdrawal by Subject43

Baseline characteristics

Characteristic30 Degrees Humeral Component RetroversionTotal0 Degrees Humeral Component Version
Age, Continuous69.19 years
STANDARD_DEVIATION 7.45
69.19 years
STANDARD_DEVIATION 7.78
69.20 years
STANDARD_DEVIATION 8.21
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
43 Participants85 Participants42 Participants
Sex: Female, Male
Female
31 Participants54 Participants23 Participants
Sex: Female, Male
Male
12 Participants31 Participants19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 421 / 43
other
Total, other adverse events
11 / 429 / 43
serious
Total, serious adverse events
1 / 423 / 43

Outcome results

Primary

Postoperative External Range of Motion (ROM)

External range of motion measurements of the shoulder in degrees

Time frame: 2 years

Population: 9 participants in the 0 degrees humeral component version and 10 patients in the 30 degrees humeral component retroversion did not complete study activities and no data was collected.

ArmMeasureValue (MEAN)Dispersion
0 Degrees Humeral Component VersionPostoperative External Range of Motion (ROM)35 degreesStandard Error 3.4
30 Degrees Humeral Component RetroversionPostoperative External Range of Motion (ROM)39 degreesStandard Error 2.1
Primary

Postoperative Internal Range of Motion (ROM)

Internal range of motion measurements of the shoulder in degrees

Time frame: 2 years

Population: 9 participants in the 0 degrees humeral component version and 10 patients in the 30 degrees humeral component retroversion did not complete study activities and no data was collected.

ArmMeasureValue (MEAN)Dispersion
0 Degrees Humeral Component VersionPostoperative Internal Range of Motion (ROM)35.5 degreesStandard Error 3.2
30 Degrees Humeral Component RetroversionPostoperative Internal Range of Motion (ROM)33.5 degreesStandard Error 2.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026